StayHappi Olmesartan Medoxomil 40mg Tablet
By StayHappi
Rx
10 Tablet in a Strip

Composition
Olmesartan Medoxomil(40mg)

Manufacturer - Sarvagunaushdhi Pvt Ltd
13Th Floor, Pearl Best Hight-1, Netaji Subhash Place, Pitampura, Delhi North Delhi DL 110034 IN

Expires on or after
July, 2025

liver
StayHappi Olmesartan Medoxomil 40mg Tablet should be used with caution in patients with severe liver disease. It may be necessary to adjust the dosage of StayHappi Olmesartan Medoxomil 40mg Tablet in these cases. It is advised to consult your doctor before using this medication if you have severe liver disease. However, no dose adjustment is recommended for patients with mild liver disease. Please follow your doctor's guidance closely when taking StayHappi Olmesartan Medoxomil 40mg Tablet.

kidney
Caution should be taken when using StayHappi Olmesartan Medoxomil 40mg Tablet in patients with kidney disease. Dosage adjustment may be necessary, so consult your doctor. Regular blood pressure monitoring is advised. Avoid using StayHappi Olmesartan Medoxomil 40mg Tablet in severe kidney disease cases.

alcohol
StayHappi Olmesartan Medoxomil 40mg Tablet can lead to increased drowsiness when taken with alcohol.

driving
Caution should be exercised when driving while taking StayHappi Olmesartan Medoxomil 40mg Tablet, as it might reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
StayHappi Olmesartan Medoxomil 40mg Tablet should not be used during pregnancy due to the known risk to the developing baby. In rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor for guidance.

breastfeeding
StayHappi Olmesartan Medoxomil 40mg Tablet should be avoided during breastfeeding as it may pass into breastmilk and harm the baby. Limited human data shows it to be unsafe for nursing mothers.
Habit Forming | No |
Chemical Class | Synthetic imidazole derivative |
Therapeutic Class | CARDIAC |
Action Class | Angiotensin receptor blockers(ARB) |
₹45
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024